1 Department of Medicine Stanford University School of Medicine Stanford CA.
2 Veterans Affairs Palo Alto Health Care System Palo Alto CA.
J Am Heart Assoc. 2019 Jan 8;8(1):e009976. doi: 10.1161/JAHA.118.009976.
Background The objective was to explore the efficacy of ablation lesion sets in addition to pulmonary vein isolation ( PVI ) for paroxysmal atrial fibrillation. The optimal strategy for catheter ablation of paroxysmal atrial fibrillation is debated. Methods and Results The SMASH-AF (Systematic Review and Meta-analysis of Ablation Strategy Heterogeneity in Atrial Fibrillation) study cohort includes trials and observational studies identified in PubMed, Scopus, and Cochrane databases from January 1 1990, to August 1, 2016. We included studies reporting single procedure paroxysmal atrial fibrillation ablation success rates. Exclusion criteria included insufficient reporting of outcomes, ablation strategies that were not prespecified and uniform, and a sample size of fewer than 40 patients. We analyzed lesion sets performed in addition to PVI ( PVI plus) using multivariable random-effects meta-regression to control for patient, study, and procedure characteristics. The analysis included 145 total studies with 23 263 patients ( PVI- only cohort: 115 studies, 148 treatment arms, 16 500 patients; PVI plus cohort: 39 studies; 46 treatment arms, 6763 patients). PVI plus studies, as compared with PVI -only studies, included younger patients (56.7 years versus 58.8 years, P=0.001), fewer women (27.2% versus 32.0% women, P=0.002), and were more methodologically rigorous with longer follow-up (29.5 versus 17.1 months, P 0.004) and more randomization (19.4% versus 11.8%, P<0.001). In multivariable meta-regression, PVI plus studies were associated with improved success (7.6% absolute improvement [95% CI, 2.6-12.5%]; P<0.01, I=88%), specifically superior vena cava isolation (4 studies, 4 treatment arms, 1392 patients; 15.1% absolute improvement [95% CI, 2.3-27.9%]; P 0.02, I=87%). However, residual heterogeneity was large. Conclusions Across the paroxysmal atrial fibrillation ablation literature, PVI plus ablation strategies were associated with incremental improvements in success rate. However, large residual heterogeneity complicates evidence synthesis.
本研究旨在探讨在肺静脉隔离(PVI)的基础上消融病灶对阵发性心房颤动的疗效。阵发性心房颤动导管消融的最佳策略仍存在争议。
SMASH-AF(心房颤动消融策略异质性的系统评价和荟萃分析)研究队列包括 1990 年 1 月 1 日至 2016 年 8 月 1 日从 PubMed、Scopus 和 Cochrane 数据库中检索到的试验和观察性研究。我们纳入了报告单次阵发性心房颤动消融成功率的研究。排除标准包括结果报告不充分、消融策略未预先规定且不统一以及样本量少于 40 例。我们使用多变量随机效应荟萃回归分析来控制患者、研究和手术特征,对 PVI 基础上增加的消融病灶(PVI 加)进行分析。该分析包括 145 项研究共 23263 例患者(PVI 仅组:115 项研究,148 个治疗臂,16500 例患者;PVI 加组:39 项研究,46 个治疗臂,6763 例患者)。与 PVI 仅组相比,PVI 加组研究的患者年龄更小(56.7 岁与 58.8 岁,P=0.001),女性比例更少(27.2%与 32.0%女性,P=0.002),且方法学更严谨,随访时间更长(29.5 个月与 17.1 个月,P<0.004),随机分组比例更高(19.4%与 11.8%,P<0.001)。多变量荟萃回归分析显示,PVI 加组的成功率提高(绝对值提高 7.6%[95%置信区间,2.6-12.5%];P<0.01,I=88%),特别是上腔静脉隔离(4 项研究,4 个治疗臂,1392 例患者;绝对值提高 15.1%[95%置信区间,2.3-27.9%];P=0.02,I=87%)。然而,仍存在较大的异质性。
在阵发性心房颤动消融文献中,PVI 加消融策略与成功率的提高相关。然而,较大的残留异质性使证据合成变得复杂。